(NASDAQ: DTIL) Precision Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.38%.
Precision Biosciences's earnings in 2026 is -$43,600,000.On average, 6 Wall Street analysts forecast DTIL's earnings for 2026 to be -$69,021,011, with the lowest DTIL earnings forecast at -$80,410,123, and the highest DTIL earnings forecast at -$46,057,011. On average, 6 Wall Street analysts forecast DTIL's earnings for 2027 to be -$63,754,772, with the lowest DTIL earnings forecast at -$79,651,536, and the highest DTIL earnings forecast at -$39,283,921.
In 2028, DTIL is forecast to generate -$63,953,449 in earnings, with the lowest earnings forecast at -$72,065,676 and the highest earnings forecast at -$51,746,406.